Atorvastatin Ameliorated PM-induced Atherosclerosis in Rats

PM2.5 provokes atherosclerotic events. Atorvastatin presents anti-inflammatory and antioxidant activities, and may ameliorate PM2.5-induced atherosclerosis development. The purpose of this study was to investigate the cardiotoxic effect of fine particulate matter (PM) on atherosclerosis (AS) in rats, and the intervention effects of atorvastatin (ATO) on PM-induced AS development. AS model was established using 32 male Wistar rats through intraperitoneal injection of vitamin D3 combined with a high-fat diet (10% fat and 4% cholesterol). The rats were randomly divided into 4 groups: control group, PM-exposed group, ATO group, and ATO treated PM-exposed group. PM increased levels of TC, TG, LDL, MDA, IL-6, and TNF-α, as well as decreased SOD levels. Besides, PM also enhanced AI. After the treatment of ATO, most levels of various contents in serum, including TC, TG, LDL, MDA, IL-6, TNF-α, hS-CRP, and ox-LDL, significantly decreased compared to the PM-exposed group. Moreover, after the treatment of ATO, AI was significantly reduced compared to the PM-exposed group. In addition, PM exacerbated the nuclear translocation and ATO resulted in an obvious decrease in PM-induced nuclear translocation. The present study suggests that PM could induce oxidative damage and systemic inflammatory response in atherosclerosis model rats, while ATO could ameliorate PM-induced atherosclerosis development, possibly by lowering lipid, inhibiting inflammation, and suppressing oxidation.